Anna is a board-certified genetic counselor with a background in neurology, rare disease, and other hereditary conditions. She holds an MS in Genetic Counseling from Sarah Lawrence College. Anna combines her expertise in genomics, and longevity science to help patients personalize their health strategies. Anna uses genetic insights to guide sustainable weight management and support long-term wellness. Her other specialties include: hereditary and sporadic neurologial conditions, rare disease, hereditary cancer syndromes, cardiac conditions, and variant interpretation.

David is a board certified genetic counselor with over 14 years of experience and is a graduate of the Genetic Counseling program from Sarah Lawrence College. He specializes in using genetic tools to support and improve health outcomes. David is passionate about equitable, compassionate care and helps patients make informed, confident choices for lasting wellness. He also has experience in prenatal/maternal-fetal medicine enjoys helping individuals navigate the complexities of genetic information and cope with the emotional and practical aspects of genetic conditions.

Anantha is passionate about empowering patients to make informed decisions. She has over 20 years of experience in biotechnology and a deep knowledge of the diagnostic and precision medicine landscape. She was most recently at Illumina leading a marketing team focused on diagnostics and precision medicine applications for rare & inherited disease and oncology, which in part inspired her to found My Precious Genes.

Chinni is a physician and healthcare executive with over 20 years of experience bringing access and quality to healthcare delivery. She has led a large multi-specialty group and most recently, was Chief Clinical Executive of Walmart Health.  Having experienced a need for genetic testing and counseling herself, she has identified the disparity that exists in access, which is what powered her passion to start My Precious Genes. 

Nandini is a practicing internal medicine physician with over a decade of experience. As a physician at Memorial Sloan Kettering Cancer Center (MSKCC), she manages patients with cancer related emergencies at MSKCC, though she has spent time working in intensive care. She has also worked with numerous healthcare startups. She believes in using the latest technology and medical developments to help people make better health decisions.

Sahana Narayan is a public health researcher and academic. She holds degrees from Harvard Medical School and Columbia University and is currently pursuing a PhD in Women’s and Reproductive Health at the University of Oxford. With years of experience leading clinical research and global health initiatives, she believes that every person deserves respectful, science-backed, and compassionate care.

Scott Weissman has over 20 years of experience in clinical genetics and has specialized in hereditary cancer syndromes and worked extensively with hereditary cardiac, neurologic, and other adult-onset genetic conditions. His expertise includes pharmacogenomics and advancing patient-centered care, and he has played a key role in founding and supporting patient advocacy groups throughout his career.

Dr. Neel Shah is a hematologist and oncologist in private practice with a strong commitment to cancer research and philanthropic work in oncology. In addition to his clinical and research expertise, he serves as a medical-legal expert and provides expert witness testimony in complex medical cases. Dr. Shah brings valuable insight at the intersection of patient care, research, and health advocacy.

Dr. Aarathi Cholkeri-Singh is the Executive Director and Chief Medical Officer at KARL STORZ United States, with deep expertise in minimally invasive gynecologic surgery and office-based gynecology. A board-certified OB/GYN since 2010 and Fellow of the American Congress of Obstetricians and Gynecologists, she brings decades of clinical leadership to women's health.

Angela Breton is a commercial growth executive with 20+ years of experience scaling healthcare and tech-enabled ventures. She specializes in revenue strategy, go-to-market acceleration, and building high-value partnerships. Angela has led $40M+ in revenue growth, developed MSO infrastructure, and advises founders and executive teams on capital readiness, enterprise sales, and strategic expansion.